{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:44:48Z","timestamp":1792003488599,"version":"4.4.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1093\/jac\/dks423","type":"journal-article","created":{"date-parts":[[2012,10,31]],"date-time":"2012-10-31T00:26:16Z","timestamp":1351643176000},"page":"539-542","source":"Crossref","is-referenced-by-count":59,"title":["High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility"],"prefix":"10.1093","volume":"68","author":[{"given":"Kouji","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satowa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Wachino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Shibayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshichika","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,10,30]]},"reference":[{"key":"key\n\t\t\t\t20170511114150_DKS423C1","first-page":"222","article-title":"Group B streptococcal infections","volume-title":"Streptococcal Infections. Clinical Aspects, Microbiology, and Molecular Pathogenesis","author":"Baker","year":"2000"},{"key":"key\n\t\t\t\t20170511114150_DKS423C2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(98)07128-1","article-title":"Group B streptococcus","volume":"353","author":"Schuchat","year":"1999","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170511114150_DKS423C3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1128\/CMR.11.3.497","article-title":"Epidemiology of Group B streptococcal disease in the United States: shifting paradigms","volume":"11","author":"Schuchat","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20170511114150_DKS423C4","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199306243282503","article-title":"A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults","volume":"328","author":"Farley","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"key\n\t\t\t\t20170511114150_DKS423C5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.7326\/0003-4819-123-6-199509150-00003","article-title":"Risk factors for group B streptococcal disease in adults","volume":"123","author":"Jackson","year":"1995","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170511114150_DKS423C6","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC","volume":"51","author":"Schrag","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20170511114150_DKS423C7","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100-S19","author":"Clinical and Laboratory Standards Institute","year":"2009"},{"key":"key\n\t\t\t\t20170511114150_DKS423C8","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1128\/AAC.00185-08","article-title":"First molecular characterization of group B streptococci with reduced penicillin susceptibility","volume":"52","author":"Kimura","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511114150_DKS423C9","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1093\/jac\/dkr352","article-title":"Predominance of sequence type 1 group with serotype VI among group B streptococci with reduced penicillin susceptibility identified in Japan","volume":"66","author":"Kimura","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511114150_DKS423C10","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1128\/AAC.00596-08","article-title":"Genetic heterogeneity in pbp genes among clinically isolated group B streptococci with reduced penicillin susceptibility","volume":"52","author":"Nagano","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511114150_DKS423C11","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/jac\/dkp374","article-title":"Molecular characterization of group B streptococci with reduced penicillin susceptibility recurrently isolated from sacral decubitus ulcer","volume":"64","author":"Nagano","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511114150_DKS423C12","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1128\/AAC.01716-08","article-title":"Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections","volume":"53","author":"Murayama","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511114150_DKS423C13","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1128\/AAC.00461-08","article-title":"Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to \u03b2-lactam antibiotics","volume":"52","author":"Dahesh","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511114150_DKS423C14","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/jac\/dkp458","article-title":"Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone","volume":"65","author":"Gaudreau","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511114150_DKS423C15","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1128\/AAC.01243-10","article-title":"Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy","volume":"55","author":"Longtin","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511114150_DKS423C16","first-page":"25","volume-title":"Breakpoint Tables for Interpretation of MICs and Zone Diameters, Version 1.3","author":"EUCAST","year":"2011"},{"key":"key\n\t\t\t\t20170511114150_DKS423C17","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1128\/JCM.02063-08","article-title":"Practical disk diffusion test for detecting group B streptococcus with reduced penicillin susceptibility","volume":"47","author":"Kimura","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170511114150_DKS423C18","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1128\/AAC.49.12.5069-5074.2005","article-title":"Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae","volume":"49","author":"Marim\u00f3n","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511114150_DKS423C19","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1128\/AAC.50.5.1875-1877.2006","article-title":"Erythromycin and clindamycin resistance in group B streptococcal clinical isolates","volume":"50","author":"Gygax","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511114150_DKS423C20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jac\/dkr546","article-title":"Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1","volume":"67","author":"Nagano","year":"2012","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/68\/3\/539\/16862085\/dks423.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T23:48:22Z","timestamp":1562284102000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dks423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,30]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,10,30]]},"published-print":{"date-parts":[[2013,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dks423","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10,30]]}}}